Who We Are

Our Movement Disorder Specialists

Clinical Trials

Weekly Classes

The Danville d’Elegance Foundation is dedicated to ‘Stop Parkinson’s in its Tracks!’ The Foundation hosts a weekend of events in September organized entirely by a dedicated team of volunteers who have been touched by Parkinson’s. The ‘jewel’ of this fundraising crown, the annual gala, is an elegant affair delivering an evening of Maria Muldaur & Her Red Hot Blusiana Band performances, great company, and delicious food and wine. This year the gala will be held on September 15, 2018 at the Blackhawk Museum in Danville, California and all proceeds benefit the Parkinson’s Institute and Clinical Center. In attendance will be young Danville local, Colin Mullan, who has recently become connected to the Parkinson’s Institute and Clinical Center by leveraging his successful car racing career to bring awareness to Parkinson’s. Join him and others in attending the Danville d’Elegance annual gala to show your support for those with Parkinson’s.

Click here to register for the event
For details visit www.danville-delegance.org     

Click her for the Event Flyer 

A big thank you to all who joined us on May 19th at Baylands Park to help raise awareness and funds to support those living with Parkinson’s and their families. Click here to see the photos from our 2018 More Talk More Walk event.

 UCB Collaborates on Parkinson’s Insight Project

We are excited about our collaboration with UCB, developers of Neupro® (rotigiotine transdermal system), a 24 hour time release patch which provides people with Parkinson’s continuous and stable delivery of their medication. UCB is working with us on our Parkinson’s Insight project to advance the understanding of medications used to treat Parkinson’s outside of a controlled clinical setting. Ideally, this study will help us deliver optimal healthcare for people living with Parkinson’s.

Read  More 

Parkinson’s Institute and Clinical Center Excited to Partner with CENTOGENE

The Parkinson’s Institute and Clinical Center and CENTOGENE have entered into a collaboration aimed at genetic screening of a large cohort of Parkinson’s patients in the US. Now, individual patients will be screened using a large customized panel carefully selected to identify pathophysiological relevant genetic variants for the development and treatment of Parkinson’s disease.  For more information click here